Optimising treatment of HIV-associated Hodgkin lymphoma
Lancet Haematol
.
2023 Aug;10(8):e563-e564.
doi: 10.1016/S2352-3026(23)00177-1.
Authors
Christian Hoffmann
1
,
Marcus Hentrich
2
Affiliations
1
ICH Study Center, Hamburg 20146, Germany; University Hospital of Schleswig Holstein, Campus Kiel, Kiel, Germany. Electronic address: hoffmann@ich-hamburg.de.
2
Red Cross Hospital Munich, University of Munich, Munich, Germany.
PMID:
37532413
DOI:
10.1016/S2352-3026(23)00177-1
No abstract available
Publication types
Comment
MeSH terms
HIV Infections* / complications
HIV Infections* / drug therapy
HIV Infections* / pathology
Hodgkin Disease* / complications
Hodgkin Disease* / drug therapy
Hodgkin Disease* / pathology
Humans
Risk Factors